Protease-activated receptor 4 deficiency offers cardioprotection after acute ischemia reperfusion injury.
about
Vitexin exerts cardioprotective effect on chronic myocardial ischemia/reperfusion injury in rats via inhibiting myocardial apoptosis and lipid peroxidation.Protease-Activated Receptor 4 (PAR4): A Promising Target for Antiplatelet Therapy.Activation of PAR4 Upregulates p16 through Inhibition of DNMT1 and HDAC2 Expression via MAPK Signals in Esophageal Squamous Cell Carcinoma Cells
P2860
Protease-activated receptor 4 deficiency offers cardioprotection after acute ischemia reperfusion injury.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年学术文章
@wuu
2015年学术文章
@zh-cn
2015年学术文章
@zh-hans
2015年学术文章
@zh-my
2015年学术文章
@zh-sg
2015年學術文章
@yue
2015年學術文章
@zh
2015年學術文章
@zh-hant
name
Protease-activated receptor 4 ...... e ischemia reperfusion injury.
@en
Protease-activated receptor 4 ...... e ischemia reperfusion injury.
@nl
type
label
Protease-activated receptor 4 ...... e ischemia reperfusion injury.
@en
Protease-activated receptor 4 ...... e ischemia reperfusion injury.
@nl
prefLabel
Protease-activated receptor 4 ...... e ischemia reperfusion injury.
@en
Protease-activated receptor 4 ...... e ischemia reperfusion injury.
@nl
P2093
P2860
P1476
Protease-activated receptor 4 ...... e ischemia reperfusion injury.
@en
P2093
Abdelkarim Sabri
Bahman Hooshdaran
Joseph R Libonati
Khadija Rafiq
Liudmila Vlasenko
Mikhail A Kolpakov
Sahar Iftikhar
Satya P Kunapuli
Xiaoxiao Zhang
P2860
P356
10.1016/J.YJMCC.2015.11.030
P577
2015-11-28T00:00:00Z